Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #6450
Reference
Drug alert 07/2019
Name
Drug alert class 2 no 7 2019: Accord Healthcare Limited: Losartan Potassium 50mg film-coated Tablets, PL 20075/0022 and Losartan Potassium 100mg film-coated Tablets, PL 20075/0023
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
Description
The MHRA has become aware of products containing Losartan Potassium that are contaminated with a nitrosamine, nitroso-N-methylamino butyric acid (NMBA).
Contact Name
Irene Fazakerley
Contact Email
Contact Address
St Andrew's House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2019-03-21 00:00:00
Click to go back to homepage